JPRN-UMIN000047941已完成未知
Japanese rehabilitation and risk factors on the post-intensive care syndrome study - J-RELIFE study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 96
研究概览
简要总结
Sixty-five patients were included in the analysis; HAD occurred in 21 patients, with significantly higher rates of motor function decline and frailty 3 months after discharge in the HAD group. The factors associated with the occurrence of HAD were grip strength at ICU discharge (OR, 0.91; 95% CI, 0.83-1.00; P=0.037) and the Functional Status Score for the ICU total (OR, 0.87; 95% CI, 0.76-1.00; P=0.036). HAD group presented with flail 3 months after discharge.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients discharged from the ICU within 48 hours (e.g., scheduled postoperative follow-up, dialysis only, etc.) 2)Diseases presenting with central nervous system disorders (stroke, severe head trauma, CNS infection, brain tumor, after neurosurgery, after cardiopulmonary resuscitation with hypoxic encephalopathy, cervical cord injury with impaired consciousness, cerebrovascular dementia, Alzheimer's disease, Parkinson's disease, etc.) 3)Patients who have difficulty communicating in Japanese or cooperating with rehabilitation, such as foreigners (including schizophrenia, anxiety, depression, autism, etc.) 4)Patients who could not walk even with the use of aids for walking before hospitalization (patients requiring nursing care 3 or more for services: approximate) 5) End of life/terminal care cases where treatment is not the objective. 6) Other patients who are deemed inappropriate by the principal investigator or research coordinator.
研究者
相似试验
已完成
不适用
Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line TherapyPeripheral T-cell LymphomaNCT06422247Bristol-Myers Squibb307
未知
1 期
A Two-Part Study in Japanese Patients With Advanced or Metastatic NSCLC. Open-Label Phase I to Assess the Safety & Tolerability of AZD2171 in Combination With Pac/Carb, Then a Phase II, Randomised, Double-Blind Study to Assess the Efficacy of AZD2171 Alone and in Combination With AZD2171 and Pac/CarbCarcinoma, Non-Small-Cell LungJPRN-jRCT2080220478AstraZeneca
已完成
不适用
Study of Arthralgia and Vasomotor Symptoms in Japanese Postmenopausal Women Treated with AnastrozolePostmenopausal breast cancersJPRN-UMIN000002455Department of Surgery, Hyogo College of Medicine391
暂停
不适用
Study of the therapy, age, complication and outcome for ruptured and unruptured cerebral aneurysm using DPCthe cerebral aneurysmJPRN-UMIN000034242Ministry of Education, Culture, Sports, Science and Technology30,000
已完成
3 期
A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal InfectionIntra-abdominal InfectionsNCT01473836Pfizer38